Welcome to Pangaea insights

Our collective intelligence provides an unrivalled breadth and depth of knowledge.

Pangaea’s ongoing relationships with key industry stakeholders facilitate continuous updates and dissemination of relevant market intelligence. Check back often for new posts!

Pangaea Express: PMPRB Decides on 1 Filing Period

March 19, 2021
After several weeks of consultation, the PMPRB has made their decision regarding the definition of Gap Medicines and the compliance timelines for Grandfathered and Gap Medicines.

Pangaea Express: Bill to Enact Pharmacare is Defeated

March 2, 2021
On February 24, the private members Bill C-213, An Act to enact the Canada Pharmacare Act, was defeated. This Bill, tabled last February 2020 by NDP MP, Peter Julian, had the support of all members of the NDP and Green Party, one Conservative, two Liberal & two independents MPs.

Pangaea Express: Another Six-Month Delay

January 4, 2021
The Government has announced the implementation of the amended Patented Medicines Regulations will be delayed once again until July 1, 2021.

The Pangaea Group Announcement

January 1, 2021
Two new appointments for The Pangaea Group effective January 1, 2021.

Pangaea Express: Health Canada responds to U.S. Drug Importation

December 1, 2020
Health Canada (HC) has issued an Interim Order (IO) to safeguard Canada’s drug supply from diversion.

Pangaea Express: The Final PMRPB Guidelines

October 23, 2020
The final PMPRB Guidelines have been published along with an "Overview of Final Changes" that differ from the June 2020 draft Guidelines.

Pangaea Express: Interim Order to expedite approval for COVID-19 medicines

September 18, 2020
On September 16, 2020, the Feds issued an Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 that allows for the Minister of Health to expedite review of COVID-19 drugs in Canada. There are three routes.

Navigating while innovating: Considerations for launching in a risk-averse environment

August 21, 2020
Sometimes the new normal is simply dealing with a new level of systematic complexity that arises as the health economy and population grows, and we grapple with an ever-expanding landscape of health system needs that are as complex as they are diverse.

Pangaea Express: Impact of the recent Federal Court decision on PMPRB Guidelines

July 9, 2020
On July 8, the PMPRB updated its website to include its views on the recent Federal Court decision pertaining to the amendments to the Patented Medicines Regulations and their impact on the Guidelines.

Join our team

June 22, 2020
Join our team: Pangaea is seeking a part-time / independent consultant to support our trade team as a Trade Manager.
← Prev
Page 1 of 10
Next →